A randomized controlled clinical study of matrix acupuncture in treatment of cervical region and shoulder region myofascitis

注册号:

Registration number:

ITMCTR2000003876

最近更新日期:

Date of Last Refreshed on:

2020-08-31

注册时间:

Date of Registration:

2020-08-31

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

矩阵针灸治疗颈肩肌筋膜炎的临床随机对照研究

Public title:

A randomized controlled clinical study of matrix acupuncture in treatment of cervical region and shoulder region myofascitis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

矩阵针灸治疗颈肩肌筋膜炎的临床随机对照研究

Scientific title:

A randomized controlled clinical study of matrix acupuncture in treatment of cervical region and shoulder region myofascitis

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000037745 ; ChiMCTR2000003876

申请注册联系人:

王立平

研究负责人:

金钰钧

Applicant:

Liping Wang

Study leader:

Yujun Jin

申请注册联系人电话:

Applicant telephone:

+86 17789670305

研究负责人电话:

Study leader's telephone:

+86 15002591639

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

625936412@qq.com

研究负责人电子邮件:

Study leader's E-mail:

243417847@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市七里河区瓜州路418号

研究负责人通讯地址:

甘肃省兰州市七里河区瓜州路418号

Applicant address:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu Province, China

Study leader's address:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu Province, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

甘肃省中医院

Applicant's institution:

Gansu Province Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020-121-01

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

甘肃省中医院伦理委员会

Name of the ethic committee:

The ethic committee of Gansu Province Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

1990/1/1 0:00:00

伦理委员会联系人:

李玉梅

Contact Name of the ethic committee:

Yumei Li

伦理委员会联系地址:

甘肃省兰州市七里河区瓜州路418号

Contact Address of the ethic committee:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

甘肃省中医院

Primary sponsor:

Gansu Province Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

甘肃省兰州市七里河区瓜州路418号

Primary sponsor's address:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省中医院

具体地址:

七里河区瓜州路418号

Institution
hospital:

Gansu Province Hospital of Traditional Chinese Medicine

Address:

418 Guazhou Road, Qilihe District

经费或物资来源:

自筹

Source(s) of funding:

self-financing

研究疾病:

颈肩部肌筋膜炎

研究疾病代码:

Target disease:

cervical region and shoulder region myofascitis

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

本研究拟采用随机对照实验比较矩阵针灸与普通针刺两种方法治疗颈部肌筋膜炎患者对比观察疼痛改善情况,验证矩阵针灸治疗颈项部肌筋膜炎的疗效。

Objectives of Study:

In this study, a randomized controlled trial was conducted to compare the pain improvement of patients with neck myofascitis treated by matrix acupuncture and moxibustion and ordinary acupuncture, so as to verify the efficacy of matrix acupuncture and moxibustion in the treatment of neck myofascitis.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合肌筋膜炎诊断标准; (2)年龄从30 至45 岁之间; (3)最近未服用其他药物及未采取其他疗法; (4)疼痛部位在颈肩局部。

Inclusion criteria

(1) Meet the diagnostic criteria for myofascitis; (2) Between the ages of 30 and 45; (3) Has not taken other drugs or taken other medical treatment recently; (4) The pain is localized in the neck and shoulder.

排除标准:

(1)关节及软组织损伤的早期; (2)合并心脑血管和造血系统等较为严重的原发性疾病; (3)具有严重的沟通或智力障碍及精神类疾病; (4)特殊时期的女性患者包括妊娠期、哺乳期或更年期严重的妇女。

Exclusion criteria:

(1) Early stage of joint and soft tissue injury; (2) Complicated with serious primary diseases such as cardiovascular and cerebrovascular diseases and hematopoietic systems; (3) Has a serious communication or mental retardation and mental illness; (4) Women in special periods include those during pregnancy, lactation or severe menopause.

研究实施时间:

Study execute time:

From 2020-08-01

To      2021-12-31

征募观察对象时间:

Recruiting time:

From 2020-09-01

To      2021-03-31

干预措施:

Interventions:

组别:

对照组

样本量:

35

Group:

Control group

Sample size:

干预措施:

常规针刺

干预措施代码:

Intervention:

Nomally acupuncture

Intervention code:

组别:

试验组

样本量:

35

Group:

Experimental group

Sample size:

干预措施:

矩阵针刺

干预措施代码:

Intervention:

Matrix acupuncture

Intervention code:

样本总量 Total sample size : 70

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省中医院

单位级别:

省级三甲医院

Institution/hospital:

Gansu Province Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

多维疲劳评价量表

指标类型:

主要指标

Outcome:

MFI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

贝克抑郁量表

指标类型:

主要指标

Outcome:

BDI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

弥漫性疼痛指数

指标类型:

主要指标

Outcome:

VAS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数量表

指标类型:

主要指标

Outcome:

PSQI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

贝克焦虑量表

指标类型:

主要指标

Outcome:

BAI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

弥漫性疼痛指数

指标类型:

主要指标

Outcome:

WPI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

健康调查简表

指标类型:

主要指标

Outcome:

SF-36

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method

盲法:

盲法采用患者设盲,评价者设盲,分析者设盲。

Blinding:

Blind method for subjects, evaluators and statisticians.

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

After June 1, 2020, by uploading data sheet.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After June 1, 2020, by uploading data sheet.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

纸质病例记录表采集数据,微软Excel软件管理数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Paper case records were collected, and Microsoft Excel software was used to manage the data

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above